MVIS US Listed Pharmaceutical 25 Index

The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
AMARIN CORPORATION PLC -ADRGB0.52%
PATTERSON COMPANIES INCUS0.60%
PERRIGO CO PLCIE1.47%
JAZZ PHARMACEUTICALS PLCIE2.82%
BAUSCH HEALTH COS INCCA2.88%
ORGANON & COUS2.91%
ELANCO ANIMAL HEALTH INCUS3.19%
CATALENT INCUS3.49%
TEVA PHARMACEUTICAL-SP ADRIL3.69%
ZOETIS INCUS3.83%
NOVO-NORDISK A/S-SPONS ADRDK4.08%
TAKEDA PHARM-ADRJP4.54%
GLAXOSMITHKLINE PLC-SPON ADRGB4.58%
AMERISOURCEBERGEN CORPUS4.79%
ELI LILLY & COUS4.82%
MCKESSON CORPUS4.84%
JOHNSON & JOHNSONUS4.87%
PFIZER INCUS5.09%
MYLAN NVNL5.13%
NOVARTIS AG-ADRCH5.25%
SANOFI-ADRFR5.26%
ASTRAZENECA PLC-SPONS ADRGB5.28%
ABBVIE INCUS5.29%
MERCK & CO. INC.US5.34%
BRISTOL-MYERS SQUIBB COUS5.43%
Items 1-25 of total 25
Up